Annabeth P. Groenman

Annabeth P. Groenman

Auto-generated profile, based on publicly available information

Annabeth P. Groenman

University of Groningen

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
AGAnnabeth P. Groenman
Annabeth P. Groenman
TJTieme Janssen
Tieme Janssen
JOJaap Oosterlaan
Jaap Oosterlaan

11 July 2014 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
DRDaniel von Rhein
Daniel von Rhein
MMMaarten Mennes
Maarten Mennes
HEHanneke van Ewijk
Hanneke van Ewijk
AGAnnabeth P. Groenman
Annabeth P. Groenman
MZMarcel P. Zwiers
Marcel P. Zwiers
JBJan Buitelaar
Jan Buitelaar

22 April 2013 in Addiction
Verified
Journal Article
Closed access
PDF file
AGAnnabeth P. Groenman
Annabeth P. Groenman
JOJaap Oosterlaan
Jaap Oosterlaan
NRNanda Rommelse
Nanda Rommelse
BFBarbara Franke
Barbara Franke
HRHerbert Roeyers
Herbert Roeyers
SFStephen V. V Faraone
Stephen V. V Faraone

2 February 2016 in European Child & Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
MLMarloes van Lieshout
Marloes van Lieshout
MLMarjolein Luman
Marjolein Luman
JTJos W. R. Twisk
Jos W. R. Twisk
HEHanneke van Ewijk
Hanneke van Ewijk
AGAnnabeth P. Groenman
Annabeth P. Groenman
JOJaap Oosterlaan
Jaap Oosterlaan
There are very few studies on the long-term outcome of children and adolescents with ADHD-combined type in Europe. The objective of the present study is to assess the 6-year outcome (including pharmacological treatment) of a large cohort of participants with ADHD-combined type (N = 347, mean age 11.4 years) in late adolescence and early adulthood. At study entry and follow-up (mean age 17.4 years), participants were comprehensively assessed on ADHD and comorbid disorders by structured psychiatric interviews and multi-informant questionnaires. Overall functioning was assessed by the Children’s Global Assessment Scale. The retention rate was 75.6 %. The majority of participants (86.5 %) persisted in a DSM-5 ADHD diagnosis, 8.4 % had a subthreshold diagnosis, and 5.1 % remitted from the disorder at follow-up. Comorbidities decreased strongly; oppositional defiant disorder: 58 > 31 %, conduct disorder: 19 > 7 %. At follow-up, mood- and anxiety disorders were virtually non-existent following strict criteria (1–3 %). Percentage of children having had pharmacological treatment at any time increased from 79 to 91 %. On the Children’s Global Assessment Scale, 48.5 % of participants were still functionally impaired at follow-up. Parental ADHD, higher ADHD symptom severity at baseline and higher parent-reported impairment at baseline positively predicted current ADHD symptom severity (R 2 = 20.9 %). Younger baseline age, higher ADHD symptom severity at baseline and higher parent-reported impairment at baseline were positively associated with poorer overall functioning (R 2 = 17.8 %). Pharmacological treatment had no (beneficial) impact on either ADHD symptom severity or overall functioning. Results confirm that ADHD is largely persistent into late adolescence with severity and family history for the disorder as important risk factors.

1 April 2022 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
TDTycho J. Dekkers
Tycho J. Dekkers
RHRianne Hornstra
Rianne Hornstra
SOSaskia Van Der Oord
Saskia Van Der Oord
MLMarjolein Luman
Marjolein Luman
PHPieter Hoekstra
Pieter Hoekstra
BHBarbara J. van Den Hoofdakker
Barbara J. van Den Hoofdakker
Behavioral parent training is an evidence-based intervention for children with attention-deficit/hyperactivity disorder (ADHD), but it is unknown which of its components are most effective. This meta-regression analysis investigated which specific behavioral techniques that parents learn in parent training are associated with effects on parental outcomes. We searched for randomized controlled trials on parent training for children with ADHD, with positive parenting, negative parenting, parenting sense of competence, parent-child relation quality, and/or parental mental health as outcome measures. After screening 23,026 publications, 29 studies contributing 138 effect sizes were included (N=2345). For each study, the dosage of 39 behavioral techniques was derived from intervention manuals, and meta-regression determined which techniques were related to outcomes. Parent training had robust small-to-medium-sized positive effects on all parental outcomes relative to control conditions, both for unblinded and probably blinded measures. A higher dosage of techniques focusing on the manipulation of antecedents of behavior was associated with better outcomes on parenting sense of competence and parental mental health, and a higher dosage of techniques focusing on reinforcement of desired behaviors was related to larger decreases in negative parenting. Higher dosages of psycho-education were negatively related to parental outcomes. Although techniques were not investigated in isolation, our results suggested that the manipulation of antecedents of behavior and reinforcement techniques are key components of parent training for children with ADHD in relation to parental outcomes. These exploratory findings may help to strengthen and tailor parent training interventions for children with ADHD.

1 August 2013 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
AGAnnabeth P. Groenman
Annabeth P. Groenman
JOJaap Oosterlaan
Jaap Oosterlaan
NRNanda N. J. Rommelse
Nanda N. J. Rommelse
BFBarbara Franke
Barbara Franke
CGCorina U. Greven
Corina U. Greven
SFStephen V. V Faraone
Stephen V. V Faraone
Background: Attention-deficit hyperactivity disorder (ADHD) is linked to increased risk for substance use disorders and nicotine dependence.Aims: To examine the effects of stimulant treatment on subsequent risk for substance use disorder and nicotine dependence in a prospective longitudinal ADHD case–control study.Method: At baseline we assessed ADHD, conduct disorder and oppositional defiant disorder. Substance use disorders, nicotine dependence and stimulant treatment were assessed retrospectively after a mean follow-up of 4.4 years, at a mean age of 16.4 years.Results: Stimulant treatment of ADHD was linked to a reduced risk for substance use disorders compared with no stimulant treatment, even after controlling for conduct disorder and oppositional defiant disorder (hazard ratio (HR) = 1.91, 95% Cl 1.10−3.36), but not to nicotine dependence (HR = 1.12, 95% Cl 0.45−2.96). Within the stimulant-treated group, a protective effect of age at first stimulant use on substance use disorder development was found, which diminished with age, and seemed to reverse around the age of 18.Conclusions: Stimulant treatment appears to lower the risk of developing substance use disorders and does not have an impact on the development of nicotine dependence in adolescents with ADHD.